Latanoprost ophthalmic solution 0.005% (XALATAN®)

DRUG5 trials

Sponsors

Alcon Research

Conditions

GlaucomaOcular HypertensionOpen-Angle GlaucomaOpen-angle Glaucoma

Phase 3

Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00690794

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2008-07-31End: 2009-05-31Updated: 2012-07-24

Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health

CompletedNCT00761319

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2008-10-31End: 2009-09-30Updated: 2012-04-26

Phase 4

A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT00527592

Alcon ResearchOcular Hypertension, Open-Angle Glaucoma

Start: 2007-05-31End: 2008-08-31Updated: 2012-05-18

Effects of Travatan Z and Xalatan on Ocular Surface Health

CompletedNCT00708422

Alcon ResearchGlaucoma, Ocular Hypertension

Start: 2008-07-31End: 2009-08-31Updated: 2012-04-23

Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN

CompletedNCT00798759

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2008-12-31End: 2009-05-31Updated: 2012-06-01